Evaluating the Effectiveness of Telemedicine in Enhancing Glycemic Control and Quality of Life for Adults with Type 1 Diabetes

The rising prevalence of Type 1 diabetes (T1D) presents significant challenges for healthcare systems and affects millions of individuals worldwide. This review evaluated the effectiveness of telemedicine in enhancing glycemic control and quality of life (QoL) for adults with T1D. Telemedicine, encompassing remote monitoring, virtual consultations, and educational support, provides a comprehensive, patient-centered approach to diabetes management. Recent studies indicated significant reductions in hemoglobin A1c (HbA1c) levels among patients utilizing telemedicine, highlighting its potential to improve glycemic outcomes. Furthermore, telemedicine fosters emotional support and social connectivity, addressing the psychosocial challenges associated with living with T1D. Through validated QoL assessment tools, findings reveal that telemedicine enhances patient-reported outcomes, including self-efficacy and overall satisfaction with diabetes care. Despite barriers such as technological limitations and regulatory issues, integrating telemedicine into healthcare systems is crucial for optimizing care. This review employed a narrative synthesis methodology to analyze existing literature and provide recommendations for the future implementation of telemedicine in diabetes management, ultimately contributing to improved health outcomes for individuals with T1D. Keywords: Telemedicine, Type 1 Diabetes, Glycemic Control, Quality of Life, Remote Monitoring.